Search
Skip to Search Results- 3Cairo, Christopher W.
- 3Guo, Tianlin
- 2Pshezhetsky, Alexey V
- 2Richards, Michele R
- 2Zou, Chunxia
- 1Datwyler, Philipp
-
Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity
Download2018-05-16
Richards, Michele R, Guo, Tianlin, Hunter, Carmanah D, Cairo, Christopher W.
Inhibitors of viral neuraminidase enzymes have been previously developed as therapeutics. Humans can express multiple forms of neuraminidase enzymes (NEU1, NEU2, NEU3, NEU4) that share a similar active site and enzymatic mechanism with their viral counterparts. Using a panel of purified human...
-
2018-11-16
Guo, Tianlin, Heon-Roberts, Rachel, Zou, Chunxia, Zheng, Ruixiang, Pshezhetsky, Alexey V, Cairo, Christopher W.
Inhibitors of human neuraminidase enzymes (NEU) are recognized as important tools for the study of the biological functions of NEU and will be potent tools for elucidating the role of these enzymes in regulating the repertoire of cellular glycans. Here we report the discovery of selective...
-
2018-01-05
Guo, Tianlin, Datwyler, Philipp, Demina, Ekaterina, Richards, Michele R, Ge, Peng, Zou, Chunxia, Zheng, Ruixiang Blake, Fougerat, Anne, Pshezhetsky, Alexey V, Ernst, Beat, Cairo, Christopher W.
Human neuraminidases (NEU) are associated with human diseases including cancer, atherosclerosis, and diabetes. To obtain small molecule inhibitors as research tools for the study of their biological functions, we designed a library of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues...